UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: B | C | D | E | G | H | I | J | L | M | N | O | P | R | S | T | W | Y
Number of items: 75.

B

Bernatsky, S; Boivin, JF; Joseph, L; Manzi, S; Ginzler, E; Urowitz, M; Gladman, D; ... et, A; + view all (2005) Race/ethnicity and cancer occurrence in systemic lupus erythematosus. Arthritis and Rheumatism , 53 pp. 781-784.

Bernatsky, S; Boivin, JF; Joseph, L; Rajan, R; Zoma, A; Manzi, S; Ginzler, EM; ... Clarke, A; + view all (2005) An international cohort study of cancer in systemic lupus erythematosus. Arthritis and Rheumatism , 52 pp. 1481-1490.

C

Cambridge, G; Leandro, MJ; Stohl, W; Ehrenstein, MR; Migone, TS; Hilbert, DM; Teodoresou, M; (2005) Relationship between circulating antibodies and BLyS following B cell depletion therapy in patients with rheumatoid arthritis. In: RHEUMATOLOGY. (pp. I73 - I73). OXFORD UNIV PRESS

Chambers, S; Isenberg, DA; (2005) Malignancy and rheumatic disease - a real association? J Rheumatology , 32 (1866) 1867-.

Chambers, S; Isenberg, DA; (2005) Autoimmunity - Systemic Lupus Erythematosus. In: Lotze, MT and Thomson, AW, (eds.) Measuring Immunity. (pp. 505-514). Elseiver: Amsterdam.

Chavez, K; Ehrenstein, M; Evans, J; Mauri, C; (2005) Could B cells have the potential to control lupus-like syndrome in MRL/lpr? In: RHEUMATOLOGY. (pp. I135 - I135). OXFORD UNIV PRESS

Chiecchio, L; Protheroe, RKM; Parker, T; Rudduck, C; Cheung, KL; Dagrada, G; Wechalekar, A; ... Ross, FM; + view all (2005) Critical importance of conventional cytogenetics in detecting prognostically significant chromosome 13 deletions in myeloma. In: BLOOD. (pp. 443A - 443A). AMER SOC HEMATOLOGY

Chinoy, H; Salway, F; Fertig, N; Shepherd, N; Tait, BD; Thomson, W; Isenberg, DA; ... Cooper, RG; + view all (2005) The UK Adult Onset Myositis Immunogenetic Collaboration (AOMIC): In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype rather than by myositis sub type. Arthritis Research and Therapy , 8 (1) R13-.

Coates, L; Erskine, P; Mall, S; Wood, S; Myles, D; Cooper, J; (2005) Atomic resolution x-ray, neutron and NMR studies of aspartic proteinase structure and function. In: Nimura, N and Mizuno, H and Helliwell, JR, (eds.) Hydrogen- and hydration-sensitive structural biology. (pp. 103-110). : Japan.

D

Daley, E; Wilkie, D; Loesch, A; Hargreaves, IP; Kendall, DA; Pilkington, GJ; Bates, TE; (2005) Chlorimipramine: A novel anticancer agent with a mitochondrial target. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS , 328 (2) pp. 623-632. 10.1016/j.bbrc.2005.01.028.

Derrett-Smith, EC; Dasgupta, B; (2005) ERDHEIM-CHESTER DISEASE: YET ANOTHER MIMIC OF POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS? RHEUMATOLOGY , 44 pp. 14-15. 10.1093/rheumatology/keh756.

Derrett-Smith, EC; Dasgupta, B; (2005) Erdheim-Chester disease: Yet another mimic of polymyalgia rheumatica and giant cell arteritis? In: RHEUMATOLOGY. (pp. I124 - I124). OXFORD UNIV PRESS

Dinc, A; Erdem, H; Rowczenio, D; Simsek, I; Pay, S; Bahce, M; Lachmann, H; (2005) Autosomal dominant periodic fever with AA amyloidosis: tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Turkish family. Journal of Nephrology , 18 (5) pp. 626-629.

Dubrey, SW; Recica, H; Grocott-Mason, R; Hawkins, PN; (2005) Panda eyes and heart failure. British Journal of Hospital Medicine , 66 (12) 701-.

E

Edwards, C; Isenberg, DA; (2005) Cyclophosphamide: time to say goodnight and goodbye? Curr Rheum Rev , 1 pp. 189-191.

Edwards, JCW; Cambridge, G; Leandro, MJ; (2005) B lymphocyte depletion therapy in autoimmune disorders: Chasing trojan Horses. In: Molecular Autoimmunity. (pp. 291-311).

Ehrenstein, MR; Evans, J; Mathews, C; Choudry, F; Mauri, C; (2005) Regulatory T cells in rheumatoid arthritis before and after anti-TNF? Therapy. In: ANNALS OF THE RHEUMATIC DISEASES. (pp. 39 - 39). B M J PUBLISHING GROUP

Erskine, PT; Coates, L; Newbold, R; Brindley, AA; Stauffer, F; Beaven, GDE; Gill, R; ... Cooper, JB; + view all (2005) Structure of yeast 5-aminolaevulinic acid dehydratase complexed with the inhibitor 5-hydroxylaevulinic acid. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY , 61 pp. 1222-1226. 10.1107/S0907444905018834.

Erskine, PT; Coates, L; Newbold, R; Brindley, AA; Stauffer, F; Beaven, GDE; Gill, R; ... Cooper, JB; + view all (2005) Structure of yeast 5-aminolaevulinic acid dehydratase complexed with the inhibitor 5-hydroxylaevulinic acid. Acta Crystallographica D , 61 (9) pp. 1222-1226. 10.1107/S0907444905018834.

Esposito, G; Corazza, A; Viglino, P; Verdone, G; Pettirossi, F; Fogolari, F; Makek, A; ... Bellotti, V; + view all (2005) Solution structure of β2-microglobulin and insights into fibrillogenesis. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics , 1753 (1) pp. 76-84. 10.1016/j.bbapap.2005.07.003.

G

Garg, N; Shand, LM; Pathak, R; Myint, F; Baker, D; Black, C; Denton, CP; (2005) Lower and upper limb macrovascular disease is uncommon in scleroderma but is amenable to angioplasty. Rheumatology , 44 I130-I130.

Giles, I; Isenberg, D; A, R; A, ; (2005) Lessons from sequence analysis of monoclonal antiphospholipid antibodies. In: Hughes Syndrome: Antiphospholipid Syndrome. Springer-Verlag

Giles, I; Lambrianides, N; Ioannou, Y; Latchman, D; Chen, P; Chukwuocha, R; Isenberg, D; (2005) Arginine residues are critical in the binding of human monoclonal antiphospholipid antibodies to beta 2glycoprotein I. In: RHEUMATOLOGY. (pp. I142 - I142). OXFORD UNIV PRESS

Giles, I; Pattni, N; Lambrianides, N; Chuckwuocha, R; Chen, P; Latchman, D; Isenberg, D; (2005) Arginine residues are important in determining the ability of human monoclonal antiphospholipid antibodies to bind prothrombin and phosphatidylserine but not phosphatidycholine. In: ARTHRITIS AND RHEUMATISM. (pp. S597 - S597). WILEY-LISS

Giles, I.P.; (2005) An investigation of the importance of somatic mutations and basic residues in the binding of antiphospholipid antibodies to cardiolipin. Doctoral thesis , University of London. Green open access
file

Gillmore, J.D.; Goodman, H.J.; Lachmann, H.J.; Offer, M.; Wechalekar, A.D.; Joshi, J.; Pepys, M.B.; (2005) Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis. Blood , 107 (3) pp. 1227-1229. 10.1182/blood-2005-08-3253.

Gillmore, JD; Wechalekar, AD; Goodmarn, HJB; Lachmann, HJ; Offer, M; Joshi, J; Hawkins, RN; (2005) Cardiac followed by autologous stem cell transplantation for systemic AL amyloidosis. In: BLOOD. (pp. 338A - 338A). AMER SOC HEMATOLOGY

Goldblatt, F; Isenberg, DA; (2005) New therapies for systemic lupus erythematosus. CLIN EXP IMMUNOL , 140 (2) 205 - 212. 10.1111/j.1365-2249.2005.02795.x. Gold open access

Goodman, HJ; Wechalekar, AD; Hawkins, PN; (2005) Amyloidosis, not myeloma. British Journal of Haematology , 129 (1) pp. 158-159.

Gorevic, PD; Hawkins, PN; Butrimiene, I; Lesnyak, O; Livneh, A; Filipowicz-Sosnowska, A; Merlini, G; ... Skinner, M; + view all (2005) Treatment of AA amyloidosis: Results of a multi-center, randomized, placebo-controlled trial with 1,3-propanedisulfonate (1,3-PDS; NC-503). In: (Proceedings) 69th Annual Scientific Meeting of the American-College-of-Rheumatology/40th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. (pp. pp. 4108-4109). WILEY-LISS

H

Hazenberg, BPC; Bijzet, J; Butrimiene, I; Livneh, A; Lesnyak, O; Nasonov, EL; Hawkins, PN; ... Hauck, W; + view all (2005) Impact of fibrillex, an anti-amyloid product, on amyloid A (AA) protein content in abdominal fat tissue biopsies from patients with AA amyloidosis: Results from a pivotal international trial. In: ANNALS OF THE RHEUMATIC DISEASES. (pp. 223 - 223). B M J PUBLISHING GROUP

Hirschfield, G.M.; Gallimore, J.R.; Kahan, M.C.; Hutchinson, W.L.; Sabin, C.A.; Benson, G.M.; Dhillon, A.P.; ... Pepys, M.B.; + view all (2005) Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. Proceedings of the National Academy of Sciences , 102 (23) pp. 8309-8314. 10.1073/pnas.0503202102.

Hoffman, IEA; Peene, I; Cebecaver, L; Isenberg, DA; Huizinga, TWA; Union, A; Meheus, L; ... De Keyser, F; + view all (2005) Presemce of rheumatoid factor and antibodies to citrullinated peptides in SLE. Presence of rheumatoid factor and antibodies to citrullinated peptides in SLE. Annals of the Rheumatic Diseases , 64 pp. 330-332.

I

Ioannou, Y; Bowman, SJ; Rahman, A; Giles, IP; (2005) Review of presentations at the 6th European Lupus Meeting 3-5 March 2005. Lupus , 14 (6) pp. 467-478. 10.1191/0961203305lu2172xx. Green open access
file

Ioannou, Y; Giles, I; Lambrianides, N; Latchman, DS; Isenberg, DA; Rahman, A; (2005) A novel, efficient, expression system of domain I of human beta2 glycoprotein I in E-coli. RHEUMATOLOGY , 44 I141 - I142.

Ioannou, Y; Lambrianides, A; Giles, IP; Latchman, DS; Isenberg, DA; Isenberg, DA; Rahman, A; (2005) Elucidating the immunodominant binding epitopes recognised by pathogenic antiphospholipid antibodies using mutational studies. In: ARTHRITIS AND RHEUMATISM. (pp. S597 - S597). WILEY-LISS

J

Jury, EC; Isenberg, DA; Mauri, C; Ehrenstein, MR; (2005) The HMG-coA reductase inhibitor atorvastatin targets lipid rafts in lupus T cells leading to restoration of their function. In: IMMUNOLOGY. (pp. 47 - 47). BLACKWELL PUBLISHING

Jury, EC; Mauri, C; Ehrenstein, M; (2005) The immunomodulatory effects of atorvastatin may be mediated by disruption of membrane microdomains. In: ANNALS OF THE RHEUMATIC DISEASES. (pp. 125 - 125). B M J PUBLISHING GROUP

Jury, EC; Mauri, C; Ehrenstein, MR; (2005) Investigation into the effects of atorvastatin on lipid rafts and T cell function in patients with systemic lupus erythematosus. In: ARTHRITIS AND RHEUMATISM. (pp. S208 - S208). WILEY-LISS

Jury, EC; Mauri, C; Ehrenstein, MR; (2005) The immunomodulatory effects of atorvastatin may be mediated by disruption of membrane microdomains. In: RHEUMATOLOGY. (pp. I17 - I17). OXFORD UNIV PRESS

L

Leandro, MJ; Edwards, JCW; Ehrenstein, MR; Cambridge, G; Isenberg, DA; (2005) Follow up study of B-lymphocyte depletion in the treatment of patients with systemic lupus erythematosus. In: RHEUMATOLOGY. (pp. I25 - I25). OXFORD UNIV PRESS

Leandro, MJ; Ehrenstein, MR; Cambridge, G; Edwards, JC; (2005) Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis. In: ARTHRITIS AND RHEUMATISM. (pp. S338 - S339). WILEY-LISS

Loesch, A; (2005) Localisation of endothelin-1 and its receptors in vascular tissue as seen at the electron microscopic level. Current Vascular Pharmacology , 3 (4) pp. 381-392.

Loesch, A; (2005) Nitric oxide synthase and endothelin in cerebrovascular nerves of the basilar artery in pregnant rat. Biomedical Research (India) , 14 pp. 1-5.

Loesch, A; (2005) Search for the causes of vein graft failure in coronary bypass surgery. In: (Proceedings) The Role of Nitric Oxide in Cardiovascular System. Slovak Academy of Sciences Workshop (COST Action 844 ESF), Medical Institutes, Slovac Academy of Sciences, Bratislava 8-10 April 2005.

Loesch, A; Glass, R; (2005) Electron microscopy and in situ hybridisation: Expression of P2Y2 receptor mRNA in the cerebellum. In: Darby, IA and Hewitson, TD, (eds.) In Situ Hybridization Protocols. (pp. 151-162). Humana Press Inc: Totowa, NJ.

M

Mason, LJ; Isenberg, DA; (2005) The pathogenesis of systemic lupus erythematosus. In: Davison, AM and Cameron, JS and Grunfeld, JP and Ponticelli, C and Ritz, E and Winearls, CG and van Ypersele, C, (eds.) Oxford Textbook of Clinical Nephrology. (pp. 809-824). Oxford University Press

Mathews, CJ; Evans, J; Choudry, F; Ehrenstein, MR; Mauri, C; (2005) Characterization of regulatory T cells in rheumatoid arthritis before and after treatment with anti-TNF alpha therapy. In: RHEUMATOLOGY. (pp. I24 - I25). OXFORD UNIV PRESS

Mclellan, S; Lakhani, K; Yang, W; Dooley, A; El-Mahdi, E; Sundaresan, M; Bruckdorfer, R; ... Hardiman, P; + view all (2005) Modification of arterial mechanisms and endothelial function in PCOS. In: CLINICA CHIMICA ACTA. (pp. S276 - S276). ELSEVIER SCIENCE BV

Merlini, G; Bellotti, V; (2005) Lysozyme: a paradigmatic molecule for the investigation of protein structure, function and misfolding. Clin Chim Acta , 357 (2) pp. 168-172. 10.1016/j.cccn.2005.03.022.

Monti, M; Amoresano, A; Giorgetti, S; Bellotti, V; Pucci, P; (2005) Limited proteolysis in the investigation of beta2-microglobulin amyloidogenic and fibrillar states. Biochim Biophys Acta , 1753 (1) pp. 44-50. 10.1016/j.bbapap.2005.09.004.

N

Ng, KP; Leandro, MJ; Edwards, JCW; Ehrenstein, M; Cambridge, G; Isenberg, DA; (2005) Repeated B cell depletion in treatment of refractory systemic lupus erythematosus. In: (Proceedings) 69th Annual Scientific Meeting of the American-College-of-Rheumatology/40th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. (pp. S197-S197). WILEY-BLACKWELL

O

Offer, M; Wechalekar, AD; Goodman, HJB; Gillmore, JD; Lachmann, HJ; Bradwell, AR; Hawkins, PN; (2005) Standard oral melphalan chemotherapy for AL amyloidosis revisited using the serum free light chain assay. In: BLOOD. (pp. 976A - 976A). AMER SOC HEMATOLOGY

P

Peterson, PL; Axford, J; Isenberg, DA; (2005) Imaging in CNS Lupus. In: Gordon, C and Ramsey-Goldman, R, (eds.) Clinical Rheumatology, Best Practice Research: Systemic Lupus Erythematosus. (pp. 727-740).

R

Rahman, A; (2005) The appropriate management of systemic lupus erythematosus on the planet Mars (poem). UNSPECIFIED

Rahman, A.; Bowman, S.J.; Giles, I.P.; Ioannou, Y.; Isenburg, D.A.; (2005) Annus Mirabilis - a guide to the 6th European Lupus meeting 3-5 March 2005. Rheumatology , 44 (8) pp. 962-964. 10.1093/rheumatology/keh702. Green open access
file

Ripley, BJM; Rahman, AA; Isenberg, DA; Latchman, DS; (2005) Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90. ARTHRITIS RHEUM , 52 (4) 1171 - 1179. 10.1002/art.21000.

Ripley, BJM; Rahman, MA; Isenberg, DA; Latchman, DS; (2005) Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90. Arthritis and Rheumatism , 52 (4) pp. 1171-1179. 10.1002/art.21000.

Robinson, J.; Waller, M.J.; Stoehr, P.; Marsh, S.G.E.; (2005) IPD - the Immuno Polymorphism Database. Nucleic Acids Research , 33 (Databa) D523-D526. 10.1093/nar/gki032. Green open access
file

S

Shoolingin-Jordan, P; McNeill, ; Al D-Bass, A; Gill, R; Wood, S; Mohammed, F; Mosley, J; (2005) Structural aspects of human PBG deaminase in relation to acute intermittant porphyria. South African Congress of Porphyria and Porphyrins

Stangou, AJ; Lachmann, HL; Goodman, HJB; Bybee, A; Rowzcenio, D; Tennent, G; Brennan, SO; ... Hawkins, PN; + view all (2005) Fibrinogen A a-chain amyloidosis: clinical features and outcome after hepatorenal or solitary kidney transplantation. In: Grateau, G and Kyle, RA and Skinner, M, (eds.) Amyloid and Amyloidosis. (pp. 312-314). CRC Press: Florida.

Stangou, AJ; Rela, M; O'Grady, J; Heneghan, M; Mathias, CJ; Muiesan, P; Sizer, L; ... Heaton, ND; + view all (2005) Fibrinogen A alpha-chain amyloidosis: Clinical features and the role of combined liver and kidney transplantation. In: HEPATOLOGY. (pp. 458A - 458A). JOHN WILEY & SONS INC

Stangou, AJ; Rela, M; O'Grady, JG; Heneghan, M; Mathias, CJ; Muiesan, P; Sizer, L; ... Heaton, ND; + view all (2005) Fibrinogen Aα-chain Amyloidosis: Clinical features and the role of combined liver and kidney transplantation. Hepatology , 42 (Su 458A-.

Sultan, SM; Isenberg, DA; Cambridge, G; Edwards, JCW; (2005) Clinical outcome in 7 patients with idiopathic inflammatory myositis treated with rituximab. In: (Proceedings) 69th Annual Scientific Meeting of the American-College-of-Rheumatology/40th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. (pp. S316-S316). WILEY-BLACKWELL

Swanton, J; Isenberg, DA; (2005) Mixed connective tissue disease: still crazy after all these years. Rheum Dis Clin N America , 31 pp. 421-436.

T

Tagalakis, AD; Dickson, JG; Owen, JS; Simons, JP; (2005) Correction of the neuropathogenic human apolipoprotein E4 (APOE4) gene to APOE3 in vitro using synthetic RNA/DNA oligonucleotides (chimeraplasts). J MOL NEUROSCI , 25 (1) 95 - 103. Green open access
file

Tahir, H; Moore, S; Ehrenstein, MR; (2005) Comparison of anti-TNF therapy in daily practice. In: RHEUMATOLOGY. (pp. I69 - I69). OXFORD UNIV PRESS

W

Walters, JR; Chavele, KM; Taylor, V; Balesaria, S; Berry, J; Khair, U; Barley, NF; (2005) Human duodenal calcium transporter TRPV6 expression: Vitamin D dependency varies with sex and age. In: (Proceedings) Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week. (pp. A248-A248). W B SAUNDERS CO

Walters, JRF; Chavele, KM; Taylor, V; Abbott, L; Balesaria, S; Khair, U; Barley, NF; (2005) Ileal bile acid transporter expression levels in patients with chronic diarrhoea. In: (Proceedings) Annual Meeting of the British-Society-of-Gastroenterology. (pp. A4-A4). B M J PUBLISHING GROUP

Wechalekar, AD; Goodman, HJB; Gillmore, JD; Lachmann, HJ; Offer, M; Bradwell, AR; Hawkins, PN; (2005) Clinical profile and treatment outcome in 92 patients with AL amyloidosis associated with IgM paraproteinaemia. In: BLOOD. (pp. 977A - 977A). AMER SOC HEMATOLOGY

Wechalekar, AD; Goodman, HJB; Gillmore, JD; Lachmann, HJ; Offer, M; Bradwell, AR; Hawkins, PN; (2005) Efficacy of risk adapted cyclophosphamide, thalidomide and dexamethasone in systemic AL amyloidosis. In: BLOOD. (pp. 976A - 976A). AMER SOC HEMATOLOGY

Wechalekar, AD; Lachmann, HJ; Gillmore, JD; Goodman, HJB; Offer, M; Hawkins, PN; (2005) The role of renal transplantation in systemic AL amyloidosis. In: BLOOD. (pp. 976A - 977A). AMER SOC HEMATOLOGY

Williams, MH; Handler, CE; Akram, R; Das, C; Smee, J; Denton, CP; Nair, D; ... Coghlan, JG; + view all (2005) Value of n-terminal pro brain natriuretic peptide in risk stratisfication and clinical management of patients with scleroderma-associated pulmonary arterial hypertension. In: CIRCULATION. (pp. U662 - U662). LIPPINCOTT WILLIAMS & WILKINS

Williams, PA; Coates, L; Mohammed, F; Gill, R; Erskine, P; Coker, A; Wood, SP; ... Cooper, JB; + view all (2005) The atomic resolution structure of methanol dehydrogenase from Methylobacterium extorquens. Acta Crystallographica D , 61 (1) pp. 75-79. 10.1107/S0907444904026964.

Y

Yee, CS; Isenberg, DA; Farewell, V; Akil, M; Bruce, IN; D'Cruz, D; Griffiths, B; ... Gordon, C; + view all (2005) BILAG-2004 captures SLE disease activity better than SLEDAI-2000. ARTHRITIS AND RHEUMATISM , 52 (9) S190 - S190.

This list was generated on Sun Aug 19 01:47:34 2018 BST.